FindTrial
Sign In

A retrospective cohort study on the relationship between the expression of SCUBE3, KRT16 and SIRT7 in breast cancer and their relationship with metastasis and prognosis

A retrospective cohort study on the relationship between the expression of SCUBE3, KRT16 and SIRT7 in breast cancer and their relationship with metastasis and prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017244
Enrollment
Unknown
Registered
2018-07-19
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Positive group:None
Negative group:No

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Breast cancer patients diagnosed by pathological findings; 2. According to clinical guidelines, patients with standardized remission to achieve clinical remission; 3. Patients with complete case data in our medical record system.

Exclusion criteria

Exclusion criteria: 1. Combine other malignant tumors; 2. Unable or unstandardized treatment; 3. After standard treatment, clinical remission has not been achieved; 4. Transfer occurs, but the transfer time cannot be tracked; 5. Sudden non-tumor-induced deaths.

Design outcomes

Primary

MeasureTime frame
SCUBE3;—

Secondary

MeasureTime frame
KRT16;SIRT7;—

Countries

China

Contacts

Public ContactXie Ni

Shenzhen Second People's Hospital

xn100@szu.edu.cn+86 13501580802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026